Craig, R G <br/><br/>
A chemically modified tetracycline inhibits streptozotocin-induced diabetic depression of skin collagen synthesis and steady-state type I procollagen mRNA.  [electronic resource] 

 -  Biochimica et biophysica acta  Apr 1998 
 - 250-60 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0006-3002 
<br/><br/><label>Standard No.: </label>10.1016/s0167-4889(98)00008-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blood Glucose--drug effects<br/>Body Weight--drug effects<br/>Collagen--antagonists & inhibitors<br/>Diabetes Mellitus, Experimental--drug therapy<br/>Intubation, Gastrointestinal<br/>Male<br/>Procollagen--antagonists & inhibitors<br/>RNA, Messenger--antagonists & inhibitors<br/>Rats<br/>Rats, Sprague-Dawley<br/>Skin--drug effects<br/>Tetracycline--administration & dosage